The Eli Lilly brand seems on the corporate’s workplace in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech firm Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly pays $3.25 billion upfront, and the remaining funds are contingent upon scientific, regulatory…
CNBC’s Jim Cramer mentioned Friday that the market’s turn into “incredibly overconfident” following the Iran-U.S. ceasefire information, which induced an enormous rally in shares this week. The S&P 500 closed Friday up 3.6% week so far. Gains had been fueled by President Donald Trump‘s two-week pause on Iranian strikes, introduced late Tuesday, which gave the…
By Michael Erman April 14 (Reuters) – Johnson & Johnson reported first-quarter earnings that beat Wall Street expectations on Tuesday and raised its full-year forecast, as robust demand for most cancers drug Darzalex and psoriasis therapy Tremfya greater than offset a steep falloff in sales of its blockbuster autoimmune drug Stelara. The drug and gadget…